Optimizing hepatitis C diagnosis through reinforcement learning feature selection and multi-model machine learning evaluation – Scientific Reports
Hepatitis C virus (HCV) infection remains a leading cause of liver cirrhosis and hepatocellular carcinoma globally, affecting approximately 50 million people with chronic infection worldwide. Traditional diagnostic approaches often rely on extensive biomarker panels, resulting in increased healthcare costs and clinical complexity without corresponding improvements in diagnostic accuracy. This study presents a novel multi-agent reinforcement learning (MARL) framework for optimizing…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
